EVGN Stock Analysis: Buy, Sell, or Hold?
EVGN - EVOGENE LTD.
$0.78
-0.03 (-3.11%)
▼
5d:
-4.41%
30d:
-6.47%
90d:
-28.75%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 20, 2026
Get Alerted When EVGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: EVGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: EVGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: EVGN is currently trading at $0.78, which is considered slightly low relative to its 30-day fair value range of $0.78 to $0.87.
Technical Outlook: Technically, EVGN is in a strong downtrend. Immediate support is located at $0.72, while resistance sits at $0.97. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: EVGN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $1.75 (+123.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EVGN is in a strong downtrend. Immediate support is located at $0.72, while resistance sits at $0.97. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: EVGN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $1.75 (+123.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$0.78 -
$0.87
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 123.3% below Wall St target ($1.75)
Fair Price Analysis
30-Day Fair Range
$0.78 -
$0.87
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.72
Resistance Level
$0.97
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.98
Wall Street Target
$1.75
(+123.3%)
Revenue Growth (YoY)
-80.5%
Profit Margin
-220.2%
Share & Embed Analysis
Last updated: April 03, 2026 12:39 AM ET
Data refreshes hourly during market hours. Next update: 1:39 AM
Data refreshes hourly during market hours. Next update: 1:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EVGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 62 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 66 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 51 HOLD |
